CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene
Drug Metabolism and Disposition · 2026-06 · 54 (6) · 100320
DOI: 10.1016/j.dmd.2026.100320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-06. Verfasst von Genki Minegishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, Graduate School of Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan. Hauptthemen laut MEDLINE: Tacrolimus, Cytochrome P-450 CYP3A, Immunosuppressive Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics, Graduate School of Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
- Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan.
- Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan; Department of Chromosome Biomedical Engineering, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Tottor…
- Department of Biopharmaceutics, Graduate School of Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan. Electronic address: kaoruk@my-pharm.ac.jp.
Förderung
- Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences
- Japan Agency for Medical Research and Development
Zitieren
APA
Minegishi, G., Hiramatsu, Y., Sugahara, M., Abe, S., Kazuki, K., Miyajima, A., Kazuki, Y., & Kobayashi, K. (2026). CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene. Drug Metabolism and Disposition, 54(6), 100320. https://doi.org/10.1016/j.dmd.2026.100320
Vancouver
Minegishi G, Hiramatsu Y, Sugahara M, Abe S, Kazuki K, Miyajima A, et al. CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene. Drug Metabolism and Disposition. 2026;54(6):100320. doi:10.1016/j.dmd.2026.100320
BibTeX
@article{Minegishi2026,
author = {Minegishi, Genki and Hiramatsu, Yuna and Sugahara, Manami and Abe, Satoshi and Kazuki, Kanako and Miyajima, Atsushi and Kazuki, Yasuhiro and Kobayashi, Kaoru},
title = {CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {6},
pages = {100320},
doi = {10.1016/j.dmd.2026.100320}
}
EUVIMED